Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced that it has been certified compliant with ISO/IEC 27001:2005, an international information security management standard. Extending to all data generation and security procedures, including OGT's CytoSure^TM and Genefficiency^TM services, biomarker discovery solutions, and the development of CytoSure Interpret Software, this certification acknowledges that data confidentiality, availability and integrity is carefully managed and controlled.

Building on the ISO 9001:2008 registration earlier this year, OGT's new ISO/IEC 27001:2005 certification provides clear evidence of robust information security to meet all customer needs. Dr Mike Evans, OGT's CEO, commented: "Being one of only 448 companies within the UK to be compliant with ISO/IEC 27001:2005 demonstrates our ongoing commitment to information security and confidentiality. It also emphasises the dedication and reliability of our team to provide high-quality products and services, while protecting the integrity and confidentiality of all information and data."

The ISO/IEC 27001:2005 certification was awarded following an assessment by the British Standards Institution (BSI).